4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000143
Chief Executive Officer sold 160,773 shares at an average $75.35 ($12,114,155)
- Chief Executive Officer acquired 148,454 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Monia Brett P · Chief Executive Officer
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +40,822 | $60.89 | $2,485,652 | 295,803 | D |
| 2026-03-09 | Exercise or conversion : show line 2 in the form 10b5-1 | +73,529 | $60.89 | $4,477,181 | 369,332 | D |
| 2026-03-09 | Sale : show line 3 in the form 10b5-1 | −7,382 | $74.11 | $547,087 | 361,950 | D |
| 2026-03-09 | Sale : show line 4 in the form 10b5-1 | −117,604 | $75.26 | $8,850,642 | 244,346 | D |
| 2026-03-09 | Sale : show line 5 in the form 10b5-1 | −1,684 | $75.58 | $127,282 | 242,662 | D |
| 2026-03-10 | Exercise or conversion : show line 6 in the form 10b5-1 | +34,103 | $60.89 | $2,076,532 | 276,765 | D |
| 2026-03-10 | Sale : show line 7 in the form 10b5-1 | −16,512 | $75.47 | $1,246,235 | 260,253 | D |
| 2026-03-10 | Sale : show line 8 in the form 10b5-1 | −17,591 | $76.34 | $1,342,909 | 242,662 | D |
| Open-market sales · 160,773 sh · avg $75.35 · $12,114,155 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-09 | Exercise or conversion : show line 9 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −40,822 | 107,632 | D |
| 2026-03-09 | Exercise or conversion : show line 10 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −73,529 | 34,103 | D |
| 2026-03-10 | Exercise or conversion : show line 11 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −34,103 | 0 | D |
Loading xslF345X05/edgardoc.xml…